Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBurping on Wegovy is one of the more unexpected side effects people mention once they start treatment. It happens because semaglutide slows the rate at which your stomach empties, which means gas builds up more easily than it used to. The good news is that for most people it improves as their body adjusts — and there are straightforward steps that can reduce it in the meantime. These are prescription-only medicines; a prescriber assesses your suitability before treatment begins and can help if symptoms feel unmanageable.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It catches people off guard. You've cut your portions, you're eating more carefully than you have in years, and yet the burping is almost worse than before Wegovy. That's not a contradiction once you understand what the medicine is doing. Semaglutide, the active ingredient in Wegovy, activates GLP-1 receptors that govern how quickly food travels out of your stomach. Slower emptying is precisely how it reduces hunger, but slower emptying also means gas has longer to accumulate before it can move on. The result, for a lot of people, is belching that feels out of proportion to what they've eaten.
The NHS medicines page for semaglutide lists burping, alongside nausea and indigestion, as a common side effect of treatment. It is not a sign the medicine isn't working or that something is medically wrong. It is a sign your digestive system is doing something new. Most people find it peaks in the first one to two weeks after a dose step-up, then eases off. If you want a fuller picture of how often individual side effects occur across the trial population, the breakdown of Wegovy side effects by percentage puts the numbers in context.
Small changes to how and what you eat can meaningfully reduce burping on Wegovy. The most effective ones cluster around pace and pressure, how fast air gets into your digestive system and how much gas your food produces once it's there.
Eat slowly. Chewing thoroughly and putting your fork down between bites gives your stomach the head start it needs when emptying is already delayed. Swallowing air while rushing through a meal is the single biggest driver of belching, and it compounds the effect of the medicine. Avoid carbonated drinks, fizzy water included. The gas they introduce has nowhere useful to go when gastric emptying is slowed. Sit upright for at least thirty minutes after eating rather than lying on the sofa; gravity helps move both food and gas in the right direction.
Fatty or heavily processed foods take longer to digest at the best of times, so they tend to linger even more on semaglutide. Smaller, more frequent meals often work better than two or three large ones. A squeeze of ginger tea after eating is a simple, evidence-adjacent option that many people find calming. Keep your Wegovy pen in the fridge door as a daily reminder to also check in with how you ate that day, dose and routine reinforce each other. For a wider look at managing uncomfortable reactions, the guide to reducing Wegovy side effects covers the full range of adjustments alongside burping.
Most burping on Wegovy is inconvenient rather than serious, and the measures above are enough for the majority of people. There are situations, though, where symptoms warrant a proper clinical conversation rather than self-management alone.
If burping comes with severe or persistent abdominal pain (particularly pain that radiates toward your back) that needs prompt medical assessment. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the symptom to watch is intense stomach pain that doesn't settle, with or without vomiting. That is distinct from the ordinary belching and mild indigestion that semaglutide commonly causes.
Similarly, if burping is accompanied by significant acid reflux, difficulty swallowing or vomiting that is preventing you from keeping fluids down, those are reasons to contact your prescriber rather than wait it out. A dose review may be appropriate, or additional support can be arranged. Suspected side effects can be reported directly at the MHRA's Yellow Card scheme, patients can submit reports themselves, and it helps build the evidence base for all users of these medicines.
There is also a cost question worth being honest about. Managing side effects well is part of what ongoing clinical support provides, and understanding what Wegovy costs in the UK includes factoring in whether that support is built into the price you're paying. Aftercare shouldn't be an extra.
Burping on its own rarely needs a formal prescription review, but the context matters. If symptoms are disrupting meals, affecting your confidence about staying on treatment or simply not improving after two or three weeks at a new dose, a prescriber should know. Our clinical team reviews every repeat order, not just when something goes wrong. That means there is a natural point in the process where you can raise side effects like this, have them taken seriously and get a considered response rather than a generic reassurance.
If you haven't yet started treatment and you're researching what Wegovy actually involves day to day, the full Wegovy treatment page covers how the medicine works, what to expect during titration, and the eligibility criteria a prescriber works through. For everything specific to burping and semaglutide across related questions, the semaglutide and burping page goes into additional detail. And if you're ready to speak to a prescriber about whether this treatment is right for you, the consultation is the right next step.
Speak to our prescribers, consultations are free, reviewed the same day by a GPhC-registered Independent Prescriber, and there's no obligation to proceed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.